Methyl Brevifolincarboxylate Attenuates Free Fatty Acid-Induced Lipid Metabolism and Inflammation in Hepatocytes through AMPK/NF-κB Signaling Pathway

The prevalence of non-alcoholic fatty liver disease (NAFLD) is one of the leading causes of chronic liver diseases worldwide. This study examined the potential protective effects of a naturally occurring polyphenolic compound, methyl brevifolincarboxylate (MBC) on fatty liver injury in vitro. The re...

Descripción completa

Detalles Bibliográficos
Autores principales: Geethangili, Madamanchi, Lin, Chiao-Wei, Mersmann, Harry J., Ding, Shih-Torng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469305/
https://www.ncbi.nlm.nih.gov/pubmed/34576229
http://dx.doi.org/10.3390/ijms221810062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469305/
https://www.ncbi.nlm.nih.gov/pubmed/34576229
http://dx.doi.org/10.3390/ijms221810062

Ejemplares similares